Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: The POSEIDON randomised controlled trial

CC BY-NC-ND 4.0 · J Neuroanaesth Crit Care 2014; 01(03): 222-224
DOI: 10.1055/s-0038-1646111

Journal Club

Thieme Medical and Scientific Publishers Private Ltd.

Sujoy Banik

¹Department of Neuroanesthesiology, All India Institute of Medical Sciences, New Delhi, India

REFERENCES
1 Stevens MA, McCullough PA, Tobin KJ, Speck JP, Westveer DC, Guido-Allen DA. et al. A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: Results of the P.R.I.N.C.E. Study: Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation. J Am Coll Cardiol 1999; 33: 403-11
2 Brar SS, Aharonian V, Mansukhani P, Moore N, Shen AY, Jorgensen M. et al. Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: The POSEIDON randomised controlled trial. Lancet 2014; 383: 1814-23
3 Briguori C, Condorelli G. Hydration in contrast-induced acute kidney injury. Lancet 2014; 383: 1786-8
4 Briguori C, Airoldi F, D'Andrea D, Bonizzoni E, Morici N, Focaccio A. et al. Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): A randomized comparison of 3 preventive strategies. Circulation 2007; 115: 1211-7
5 Brigouri C, Visconti G, Focaccio A, Airoldi F, Valgimigli M, Sangiorgi GM. et al. Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II): Renal Guard System in High-Risk Patients for Contrast-Induced Acute Kidney Injury. Circulation 2011; 124: 1260-9
6 Tasanarong A, Vohakiat A, Hutayanon P, Piyayotai D. New strategy of α- andγ-tocopherol to prevent contrast-induced acute kidney injury in chronic kidney disease patients undergoing elective coronary procedures. Nephrol Dial Transplant 2013; 28: 337-44